Clinical Trials List
2024-07-01 - 2026-12-31
Phase I/II
Recruiting3
ICD-10G71.11
Myotonic muscular dystrophy
ICD-10G71.12
Myotonia congenita
ICD-10G71.13
Myotonic chondrodystrophy
ICD-10G71.14
Drug induced myotonia
ICD-10G71.19
Other specified myotonic disorders
ICD-9359.2
Myotonic disorders
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ming-Jen Lee Division of Neurology
- 薛頌儒 Division of Neurology
- 楊智超 Division of Neurology
- SUNG-TSANG HSIEH Division of Neurology
- 范淞斌 Division of Neurology
- 趙啓超 Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蕭丞宗 Division of Neurology
- Kon-Ping Lin Division of Neurology
- 季康揚 Division of Neurology
- 賴冠霖 Division of Neurology
- 吳宏達 Division of Radiology
- Yi-Chu Liao Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃上芝 Division of Neurology
- Fu-Yu Lin Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
36 participants
